IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Copernicus Capital Management, LLC

Q1 2021 Holdings

Filed 2021-05-17 | 14 holdings | $2.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$755.0K10,00037.4%
Abbvie Inc(ABBV)COM00287Y109$649.0K6,00032.1%
Ardelyx Inc(ARDX)COM039697107$331.0K50,00016.4%
Arcus Biosciences Inc(RCUS)COM03969F109$281.0K10,00013.9%
Regeneron Pharmaceuticals(REGN)COM75886F107$7101,5000.0%
Fate Therapeutics Inc(FATE)COM31189P102$6608,0000.0%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$6453,0000.0%
Revolution Medicines Inc(RVMD)COM76155X100$45910,0000.0%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$3558,0000.0%
Gritstone Oncology Inc(2JQ)COM39868T105$34937,0000.0%
TG Therapeutics Inc(TGTX)COM88322Q108$3377,0000.0%
Atreca Inc(BCELUSD)CL A COM04965G109$27618,0000.0%
Teladoc Health Inc(TDOC)COM87918A105$2731,5000.0%
Orchard Therapeutics PLCADS68570P101$10915,0000.0%